COVID-19 and Kidney Cancer

Patients with kidney cancer and their families wonder about the risk presented by the novel Coronavirus. Patients need reliable information, and we wanted to share some excellent resources from reputable sources such as the NIH, CDC, ASCO, and the FDA. We aim to provide you with facts from credible sources with established expertise in the kidney cancer community.

KidneyCAN, along with doctors and other kidney cancer organizations, participated in a “Virtual Town Hall” to discuss kidney cancer care in the time of COVID-19.

Hear from patient advocates (beginning 00:02:25), medical experts (beginning 00:41:45), and pharmaceutical experts (beginning 01:24:00) with strategies and information for navigating your cancer treatment through the pandemic. A Q & A session follows at 00:01:46.

The American Society of Clinical Oncology (ASCO) and the National Coalition for Cancer Survivorship (NCCS) provide information about COVID-19 could potentially affect those diagnosed with cancer.

This practical guide comes from an NIH Comprehensive Cancer Center and outlines cancer and COVID-19 so you can take the best care of your health.

This article discusses the impact of the COVID-19 outbreak on kidney cancer research and clinical trials.

This is a page developed at that answers many FAQs on the impact of the coronavirus on cancer patients and their treatment.

This article from the American Cancer Society reviews questions you may have and what to ask your healthcare team.

In this episode of the podcast, the host and the guests discuss the many implications and unknowns regarding the coronavirus for those with renal cell carcinoma.

If you haven’t already joined, consider connecting with the Smart Patients kidney cancer community to connect with other patients, caregivers, and medical professionals.